Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyâ
2026-03-17KALA144ANDREW I KOVEN plan to sell securities of KALA BIO, INC. under Form 144MEDIUM
ANDREW I KOVEN filed Form 144 to notify SEC of plan to sell 14466 units of KALA BIO, INC. securities around 2026-03-17, with aggregate market value of $3,816.13. The total outstanding units is 8209725.0. The amount planned to be sold represents 0.18% of total outstanding units; ...
Nano CapBiotechnology
2026-03-17MLYS144Rodman David Malcom plan to sell securities of Mineralys Therapeutics, Inc. under Form 144MEDIUM
Rodman David Malcom filed Form 144 to notify SEC of plan to sell 417 units of Mineralys Therapeutics, Inc. securities around 2026-03-17, with aggregate market value of $10,696.05. The total outstanding units is 82399478.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in...
Mid CapBiotechnology
2026-03-17MIRM144Christopher Peetz plan to sell securities of MIRUM PHARMACEUTICALS, INC. under Form 144MEDIUM
Christopher Peetz filed Form 144 to notify SEC of plan to sell 40985 units of MIRUM PHARMACEUTICALS, INC. securities around 2026-03-16, with aggregate market value of $3,796,850.40. The total outstanding units is 60341617.0. The amount planned to be sold represents 0.07% of total outstanding units; Recent transactions ...
Mid CapBiotechnology
2026-03-17MIRM144Peter Radovich plan to sell securities of MIRUM PHARMACEUTICALS, INC. under Form 144MEDIUM
Peter Radovich filed Form 144 to notify SEC of plan to sell 16515 units of MIRUM PHARMACEUTICALS, INC. securities around 2026-03-16, with aggregate market value of $1,529,949.60. The total outstanding units is 60341617.0. The amount planned to be sold represents 0.03% of total outstanding units; Recent transactions in ...
Mid CapBiotechnology
2026-03-17MIRM144Joanne Quan plan to sell securities of MIRUM PHARMACEUTICALS, INC. under Form 144MEDIUM
Joanne Quan filed Form 144 to notify SEC of plan to sell 7287 units of MIRUM PHARMACEUTICALS, INC. securities around 2026-03-16, with aggregate market value of $675,067.68. The total outstanding units is 60341617.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3...
Mid CapBiotechnology